Guardant Health Inc. Common Stock vs Lumentum — how do they compare? Guardant Health Inc. Common Stock trades at $167.39 (market cap $22.22B), while Lumentum trades at $1,109.33 (market cap $94.99B). The key difference: Lumentum is far larger — about 4.3× Guardant Health Inc. Common Stock's market cap, and Lumentum is more actively traded (4,855,776 versus 1,589,453). Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and Lumentum for 4 Days on average.
| GH | LITE | |
|---|---|---|
Market Cap | $22.22B | $94.99B |
Volume | 1,589,453 | 4,855,776 |
Sector | Health | Technology |
52-Week High | $187.22 | $1.13K |
52-Week Low | $61.73 | $149.61 |
Typical Hold Time | 1 Days | 4 Days |
Enterprise Value | $22.86B | $93.92B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →